$SHPH·8-K

Shuttle Pharmaceuticals Holdings, Inc. · Jun 30, 7:27 PM ET

Compare

Shuttle Pharmaceuticals Holdings, Inc. 8-K

Research Summary

AI-generated summary

Updated

Shuttle Pharmaceuticals Announces Subsidiary Starts DOGE Mining; Buys Miners

What Happened

  • Shuttle Pharmaceuticals Holdings, Inc. (through its wholly‑owned subsidiary United Dogecoin Inc.) announced on June 25–26, 2026 that United Dogecoin has begun evaluating proprietary data‑center and power‑generation opportunities to support long‑term DOGE mining operations and future AI workloads.
  • On June 26, 2026 the subsidiary disclosed it purchased its first fleet of ElphaPex DG1+ mining units; the units are expected to be deployed and fully operational within approximately 60 days, subject to delivery and installation schedules. United Dogecoin also secured a site to operate the units with renewable energy priced at US$0.064 per kilowatt‑hour.

Key Details

  • Subsidiary: United Dogecoin Inc., wholly owned by Shuttle Pharmaceuticals.
  • Hardware purchased: ElphaPex DG1+ mining units (first fleet), announced June 26, 2026.
  • Deployment timeline: expected to be fully operational in ~60 days, subject to delivery/installation.
  • Power economics: secured site offering renewable energy at US$0.064/kWh; evaluating behind‑the‑meter generation opportunities in Idaho (USA) and Alberta (Canada).

Why It Matters

  • These actions signal Shuttle’s subsidiary is moving from planning into execution for cryptocurrency mining and related AI/high‑performance computing infrastructure, which could introduce new operational activities and costs (and potential revenues) separate from Shuttle’s core business.
  • Securing relatively low‑cost renewable power (US$0.064/kWh) and evaluating behind‑the‑meter assets may improve operating economics if the mining operations scale, but the filing contains no financial projections or revenue guidance.
  • Investors should note this is an early‑stage operational initiative (forward‑looking) announced via press releases (filed as Exhibits 99.1 and 99.2); outcomes, costs, and timing remain subject to delivery, installation and other uncertainties.

Loading document...